Document Type
Article
Publication Date
2-7-2024
Abstract
OBJECTIVE: The current study aimed to identify the association between COVID-19 vaccination and prolonged post-COVID symptoms (long-COVID) in adults who reported suffering from this condition.
METHODS: This was a retrospective follow-up study of adults with long-COVID syndrome. The data were collected during a phone call to the participants in January-February 2022. We inquired about their current health status and also their vaccination status if they agreed to participate.
RESULTS: In total, 1236 people were studied; 543 individuals reported suffering from long long- COVID (43.9%). Chi square test showed that 15 out of 51 people (29.4%) with no vaccination and 528 out of 1185 participants (44.6%) who received at least one dose of any vaccine had long long- COVID symptoms (p = 0.032).
CONCLUSIONS: In people who have already contracted COVID-19 and now suffer from long-COVID, receiving a COVID vaccination has a significant association with prolonged symptoms of long-COVID for more than one year after the initial infection. However, vaccines reduce the risk of severe COVID-19 (including reinfections) and its catastrophic consequences (e.g., death). Therefore, it is strongly recommended that all people, even those with a history of COVID-19, receive vaccines to protect themselves against this fatal viral infection.
Recommended Citation
Asadi-Pooya, Ali Akbar; Nemati, Meshkat; Shahisavandi, Mina; Nemati, Hamid; Karimi, Afrooz; Jafari, Anahita; Nasiri, Sara; Mohammadi, Seyyed Saeed; Rahimian, Zahra; Bayat, Hossein; Akbari, Ali; Emami, Amir; and Eilami, Owrang, "How Does COVID-19 Vaccination Affect Long-COVID Symptoms?" (2024). Department of Neurology Faculty Papers. Paper 336.
https://jdc.jefferson.edu/neurologyfp/336
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Long long-COVID and vaccine study, Fars, Iran.docx (14 kB)
Inclusivity in global research.docx (64 kB)
response letter.docx (19 kB)
response letter 2.docx (14 kB)
response letter 3.docx (14 kB)
PubMed ID
38324547
Language
English
Included in
Bioethics and Medical Ethics Commons, Pathological Conditions, Signs and Symptoms Commons
Comments
This article is the author's final published version in PLoS ONE, Volume 19, Issue 2, February 2024, Article number e0296680.
The published version is available at https://doi.org/10.1371/journal.pone.0296680.
Copyright © 2024 Asadi-Pooya et al.